Number | Ticker | Country | Founded | IPO Year | Price | Revenue | Analyst Decision | Analyst Count |
---|---|---|---|---|---|---|---|---|
1 | INTRInter & Co. Inc. | Brazil | 1994 | N/A | $6.03 | $767,729,562.00 | Strong Buy | 4 |
2 | MITTAG Mortgage Investment Trust Inc. | United States | 2011 | 2011 | $6.74 | $80,741,000.00 | Strong Buy | 5 |
3 | SVVSavers Value Village Inc. | United States | 1954 | 2023 | $9.08 | $1,518,397,000.00 | Buy | 5 |
4 | EWCZEuropean Wax Center Inc. | United States | 2004 | 2021 | $5.50 | $223,500,000.00 | Buy | 7 |
5 | BDSXBiodesix Inc. | United States | 2005 | 2020 | $1.26 | $65,562,000.00 | Strong Buy | 4 |
6 | JRVRJames River Group Holdings Ltd. | Bermuda | 2002 | 2005 | $4.50 | $796,817,000.00 | Buy | 5 |
7 | ABUSArbutus Biopharma Corporation | United States | N/A | N/A | $3.52 | $6,742,000.00 | Strong Buy | 4 |
8 | RLAYRelay Therapeutics Inc. | United States | 2015 | 2020 | $4.89 | $10,006,000.00 | Strong Buy | 9 |
9 | NVTSNavitas Semiconductor Corporation | United States | 2014 | N/A | $1.78 | $91,381,000.00 | Buy | 8 |
10 | SVRASavara Inc. | United States | N/A | N/A | $2.96 | $0.00 | Buy | 6 |
11 | BRDGBridge Investment Group Holdings Inc. | United States | 2009 | 2021 | $9.56 | $404,932,000.00 | Buy | 8 |
12 | NVAXNovavax Inc. | United States | 1987 | 1995 | $7.83 | $885,193,000.00 | Buy | 6 |
13 | KALVKalVista Pharmaceuticals Inc. | United States | N/A | N/A | $9.30 | $0.00 | Strong Buy | 4 |
14 | LQDALiquidia Corporation | United States | 2004 | 2018 | $9.82 | $15,610,000.00 | Strong Buy | 8 |
15 | GNLGlobal Net Lease Inc. | United States | 2011 | N/A | $7.30 | $812,621,000.00 | Buy | 5 |
16 | AURAAura Biosciences Inc. | United States | 2007 | 2021 | $9.22 | $0.00 | Strong Buy | 4 |
17 | ANVSAnnovis Bio Inc. | United States | 2008 | 2020 | $6.82 | $0.00 | Strong Buy | 6 |
18 | OABIOmniAb Inc. | United States | 2012 | N/A | $3.72 | $20,409,000.00 | Strong Buy | 4 |
19 | ENTAEnanta Pharmaceuticals Inc. | United States | 1995 | 2013 | $9.57 | $71,960,000.00 | Buy | 4 |
20 | VSATViaSat Inc. | United States | 1986 | 1996 | $7.28 | $4,527,274,000.00 | Buy | 7 |
21 | SGMTSagimet Biosciences Inc. Series A | United States | 2006 | 2023 | $4.36 | $0.00 | Strong Buy | 5 |
22 | LNZALanzaTech Global Inc. | United States | 2005 | N/A | $1.01 | $58,025,000.00 | Strong Buy | 4 |
23 | WOOFPetco Health and Wellness Company Inc. | United States | 1965 | 2021 | $3.94 | $6,221,537,000.00 | Buy | 12 |
24 | VIGLVigil Neuroscience Inc. | United States | 2020 | 2022 | $2.94 | $0.00 | Buy | 5 |
25 | APLTApplied Therapeutics Inc. | United States | 2016 | 2019 | $8.81 | -$212,000.00 | Strong Buy | 5 |
26 | AHCOAdaptHealth Corp. | United States | N/A | N/A | $9.57 | $3,262,564,000.00 | Strong Buy | 5 |
27 | ALLOAllogene Therapeutics Inc. | United States | 2017 | 2018 | $2.17 | $43,000.00 | Buy | 12 |
28 | IMUXImmunic Inc. | United States | 2016 | N/A | $1.07 | $0.00 | Strong Buy | 5 |
29 | INFNInfinera Corporation | United States | 2000 | 2007 | $6.64 | $1,457,515,000.00 | Buy | 9 |
30 | NKTXNkarta Inc. | United States | 2015 | 2020 | $2.49 | $0.00 | Strong Buy | 5 |
31 | VIRVir Biotechnology Inc. | United States | 2016 | 2019 | $7.03 | $78,618,000.00 | Buy | 5 |
32 | PRMEPrime Medicine Inc. | United States | 2019 | 2022 | $3.18 | $800,000.00 | Strong Buy | 8 |
33 | BMEABiomea Fusion Inc. | United States | 2017 | 2021 | $6.43 | $0.00 | Buy | 13 |
34 | TCRXTScan Therapeutics Inc. | United States | 2018 | 2021 | $4.20 | $9,362,000.00 | Strong Buy | 5 |
35 | LXEOLexeo Therapeutics Inc. | United States | 2017 | 2023 | $6.00 | $0.00 | Strong Buy | 7 |
36 | ALMSALUMIS INC | United States | 2021 | 2024 | $8.64 | $0.00 | Strong Buy | 6 |
37 | OLMAOlema Pharmaceuticals Inc. | United States | 2006 | 2020 | $8.63 | $0.00 | Strong Buy | 5 |
38 | NYXHNyxoah SA | Belgium | 2009 | 2021 | $8.18 | $5,668,079.00 | Strong Buy | 5 |
39 | CLNEClean Energy Fuels Corp. | United States | 2001 | 2007 | $2.68 | $413,396,000.00 | Strong Buy | 4 |
40 | CCCCC4 Therapeutics Inc. | United States | 2015 | 2020 | $4.20 | $33,668,000.00 | Buy | 6 |
41 | HOOKHOOKIPA Pharma Inc. | United States | 2011 | 2019 | $2.80 | $49,999,000.00 | Strong Buy | 4 |
42 | IMNMImmunome Inc. | United States | 2006 | 2020 | $9.44 | $10,129,000.00 | Strong Buy | 5 |
43 | PSNLPersonalis Inc. | United States | 2011 | 2019 | $3.59 | $87,489,000.00 | Strong Buy | 4 |
44 | LRMRLarimar Therapeutics Inc. | United States | N/A | N/A | $6.16 | $0.00 | Strong Buy | 8 |
45 | ACRVAcrivon Therapeutics Inc. | United States | 2018 | 2022 | $6.27 | $0.00 | Strong Buy | 5 |
46 | TSVT2seventy bio Inc. | United States | 2021 | N/A | $3.36 | $45,620,000.00 | Buy | 6 |
47 | EVGOEVgo Inc. | United States | 2010 | N/A | $5.37 | $239,306,000.00 | Strong Buy | 10 |
48 | ANGIAngi Inc. | United States | 2017 | 2017 | $1.91 | $1,217,676,000.00 | Buy | 8 |
49 | ADVMAdverum Biotechnologies Inc. | United States | 2006 | 2014 | $6.85 | $1,000,000.00 | Strong Buy | 6 |
50 | SEATVivid Seats Inc. | United States | 2001 | N/A | $3.39 | $774,076,000.00 | Strong Buy | 9 |
The FinQuota filters have identified what they believe to be the "Best Under $10 Stocks to Buy on November 19, 2024" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.